Mesothelioma: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Terminated

  CT-95 in Advanced Cancers Associated With Mesothelin Expression

  NCT06756035· Context Therapeutics Inc.· Updated 5 Nov 2026

  “The study was halted prematurely and will not resume; participants are no longer receiving intervention or undergoing evaluations. The termination was not due to any safety or efficacy concerns.”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

  NCT01950572· National Cancer Institute (NCI)· Source

• Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

  NCT04847063· National Cancer Institute (NCI)· Source

• Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

  NCT06885697· National Cancer Institute (NCI)· Source

• Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome

  NCT04431024· National Cancer Institute (NCI)· Source

• 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

  NCT06503146· National Cancer Institute (NCI)· Source

• Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma

  NCT04577326· Memorial Sloan Kettering Cancer Center· Source

• Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

  NCT05001880· National Cancer Institute (NCI)· Source

• Implantable Microdevices for in Situ Evaluation of Drug Responses in Lung Cancer

  NCT07892300· Oliver Jonas· Source

• MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma

  NCT06097728· AstraZeneca· Source

• Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1

  NCT03830229· National Cancer Institute (NCI)· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 3
• Organoids 3
• Mendelian Randomization Analysis 1
• Gene Expression Profiling 6
• Exome Sequencing 3
• Proteomics 8
• Mass Spectrometry 3
• Flow Cytometry 6
• Immunohistochemistry 26
• Xenograft Model Antitumor Assays 21
• Positron-Emission Tomography 3
• Magnetic Resonance Imaging 3
• Machine Learning 6
• Deep Learning 1
• Cohort Studies 10
• Genome-Wide Association Study 3

See which targets of this disease your abstract mentions, and go to the people working on them.